United Therapeutics Corporation

Symbol: UTHR

NASDAQ

232.59

USD

Market price today

  • 11.1005

    P/E Ratio

  • -0.0944

    PEG Ratio

  • 10.95B

    MRK Cap

  • 0.00%

    DIV Yield

United Therapeutics Corporation (UTHR) Financial Statements

On the chart you can see the default numbers in dynamics for United Therapeutics Corporation (UTHR). Companys revenue shows the average of 818.108 M which is 0.791 % gowth. The average gross profit for the whole period is 745.38 M which is -0.009 %. The average gross profit ratio is 0.726 %. The net income growth for the company last year performance is 0.354 % which equals 0.496 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of United Therapeutics Corporation, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.186. In the realm of current assets, UTHR clocks in at 3551 in the reporting currency. A significant portion of these assets, precisely 2994.1, is held in cash and short-term investments. This segment shows a change of -0.279% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 1909.8, if any, in the reporting currency. This indicates a difference of 45.100% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 300 in the reporting currency. This figure signifies a year_over_year change of -0.125%. Shareholder value, as depicted by the total shareholder equity, is valued at 5984.8 in the reporting currency. The year over year change in this aspect is 0.248%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 278.9, with an inventory valuation of 111.8, and goodwill valued at 33.7, if any. The total intangible assets, if present, are valued at 80.5.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

balance-sheet.row.cash-and-short-term-investments

15496.42994.14154.93580.6
2984.6
2253.4
1858.5
1430.1
1050.8
953.8
695.5
688.5
479.2
403.5
627.1
229.5
236
290.1
227.7
125.5
82.8
68.6
122.7
56
215.4
51.6
6.8

balance-sheet.row.short-term-investments

10950.21786.41877.51035.9
1096.3
747.5
746.7
222.3
27.8
122
297.8
409.6
325.2
240.8
374.9
129.1
106.6
150.7
136.7
56.3
0.2
0
0
31.7
14.5
33.3
0

balance-sheet.row.net-receivables

944.7278.9220.4198.7
157.4
151.4
175.7
297.1
214.5
192.8
162.3
126.3
116.6
88.7
73.7
53.3
30.6
29.7
25.6
18.8
14.8
10.6
9.7
4.2
2.4
0.4
0.1

balance-sheet.row.inventory

421.9111.810293.8
86.5
93.4
101
107.9
100
81.3
66.9
47.8
37.3
46
35.5
26.4
14.4
13.2
12
11.3
8
8.1
7.2
6
2.9
0
0

balance-sheet.row.other-current-assets

4017.2166.2219.2100.4
88.3
133.8
75.4
115.5
59.5
47.4
49.4
46.4
3.8
6.2
759.9
15.4
16.4
19.5
0.1
0.2
1.7
0.6
1.1
1.8
1.5
0.7
9.9

balance-sheet.row.total-current-assets

13416.335513380.32323.6
2167.2
1864.5
1768
1447.9
1424.8
1275.3
974.2
909
668.5
562.5
765.1
324.5
297.4
352.5
277.4
166.8
110.5
89.7
141.9
69
222.1
52.7
16.8

balance-sheet.row.property-plant-equipment-net

38731045.4861.5780.9
731.6
738.5
699.7
545.7
489.3
495.8
478.4
464.9
453.7
366
306
303.9
221.1
69.4
34.7
21.8
17.8
15.2
9.1
6.4
5.9
3.8
1.3

balance-sheet.row.goodwill

33.733.72828
28
28
31.5
13.7
10.3
10.3
10.3
10.7
10.5
8.1
2.5
8.8
7.5
7.5
7.5
7.5
7.5
0
7.5
0
0
0
0

balance-sheet.row.intangible-assets

213.980.516.516.6
130.1
130.3
139.3
31.9
23.5
18.1
19.2
3.4
5.9
14
7.4
9.7
0.4
1
3.1
13
13.4
13.9
14.5
15.4
17.5
2.7
0

balance-sheet.row.goodwill-and-intangible-assets

247.6114.244.544.6
158.1
158.3
170.8
45.6
33.8
28.4
29.5
14.1
16.4
22.1
9.9
18.4
7.8
8.4
10.6
13
13.4
13.9
14.5
15.4
17.5
2.7
0

balance-sheet.row.long-term-investments

7759.81909.81316.21649.9
1149.6
767.5
442.6
502.7
2.3
38
122.8
453.5
311.1
349
138
188.6
146
9.7
36.4
44.9
46.2
0
10
116249
0
0
0

balance-sheet.row.tax-assets

1367.9394.8327.7261.9
238.6
230
95.7
113.4
178.3
192.7
181.7
192.7
150.1
190.7
202.1
201
176
93.7
66.9
15.1
-46.2
0
-10
-116249
0
0
0

balance-sheet.row.other-non-current-assets

553.3151.8114.3108.2
169.9
154.6
224.2
224.1
197.1
154.3
97.8
53.3
26.8
27.7
10.6
15.2
23
53.3
52.6
29.9
65.4
60.6
19.1
121.4
5
0.7
0.6

balance-sheet.row.total-non-current-assets

13801.636162664.22845.5
2447.8
2048.9
1633
1431.5
900.8
909.1
910.2
1178.6
958.1
955.6
666.6
727
573.9
234.6
201.2
124.7
96.7
89.8
42.7
143.1
28.5
7.2
1.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

27217.971676044.55169.1
4615
3913.4
3401
2879.4
2325.6
2184.4
1884.4
2087.6
1626.6
1518.1
1431.6
1051.5
871.3
587
478.6
291.4
207.2
179.5
184.6
212.1
250.6
59.9
18.7

balance-sheet.row.account-payables

870.75.64.13.8
4.1
9.9
23.1
8.4
8.1
7.5
7
6.7
10.2
47.3
16.1
18.8
20.3
2
3.1
4
6.1
4.3
3
6.7
6
2.3
1.7

balance-sheet.row.short-term-debt

70040000
0
250
0
0
0
5.4
126.5
282.5
0
0
236
220.3
0
250
0
0
0
0.8
0.1
0.1
0.1
0.1
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

2400300800800
800
600
250
250
0
0
0
3.7
275
194.2
68.9
30.3
279.2
0
250
0
0
0
1.8
1.8
1.8
1.8
0.3

Deferred Revenue Non Current

-42.4-42.4-41-30
-27.4
-45.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

42.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

678.371339.1301.6
319.2
39.6
253.5
436.3
324.4
57.5
10.3
25
166.6
165.3
126.3
61.4
37.5
2.8
0.9
0.1
0
0.1
1.8
0.6
5.5
2.2
0.1

balance-sheet.row.total-non-current-liabilities

2743.4377.8904.6904.8
896.5
670
316.6
313.7
130.9
144
114.5
95.6
355
357
119.1
68.3
305.8
18.5
254.7
1.8
1.7
1.1
3.6
4.9
4.4
1.7
0.2

balance-sheet.row.other-liabilities

0000
0
0
19.2
19.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
3
0
0
0
0
0
0
0
0
0
30.3
29.3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

4986.81182.21247.81210.2
1219.8
1133
612.4
777.6
463.4
584.8
618.8
783.3
531.7
569.6
547.7
398.5
363.6
291.2
273.9
16.3
15.5
11.7
12.9
15.7
15.9
6.3
2

balance-sheet.row.preferred-stock

0000
0
0
19.2
19.2
10.9
11.1
23.2
45
10.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2.80.70.70.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.6
0.6
0.6
0.6
0.6
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0

balance-sheet.row.retained-earnings

22662.76027.15042.34315
3839.2
3325.2
3434.8
2845.6
2433.5
1719.8
1068.1
728
553.5
249
31.2
-74.7
-78.5
-21.5
-41.4
-115.3
-180.3
-195.4
-185.8
-162.2
-124.9
-49.3
-15.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

-145.9-12.8-55.5-23
-14.2
-14.2
-7.9
-19.6
-16.8
-20.4
-16.7
-13.2
-15
-10.9
-9.2
-4.3
-5.9
0.3
1.5
3.6
2.7
1.7
0
-1.4
-0.5
-0.2
0

balance-sheet.row.other-total-stockholders-equity

-288.5-30.2-190.8-333.8
-430.5
-531.3
-658.2
-744.1
-566.1
-111.5
190.3
543.8
544.8
709.7
861.3
731.5
591.9
316.7
244.2
386.6
369.1
361.3
357.3
359.7
359.9
102.9
32.5

balance-sheet.row.total-stockholders-equity

22231.15984.84796.73958.9
3395.2
2780.4
2788.6
2101.8
1862.2
1599.6
1265.6
1304.3
1094.9
948.5
883.9
653
507.7
295.8
204.6
275.1
191.6
167.8
171.7
196.4
234.7
53.6
16.7

balance-sheet.row.total-liabilities-and-stockholders-equity

27217.971676044.55169.1
4615
3913.4
3401
2879.4
2325.6
2184.4
1884.4
2087.6
1626.6
1518.1
1431.6
1051.5
871.3
587
478.6
291.4
207.2
179.5
184.6
212.1
250.6
59.9
18.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

22231.15984.84796.73958.9
3395.2
2780.4
2788.6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

27217.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

9546.23696.23193.72685.8
2245.9
1515
1189.3
725
30.1
160
420.6
863.1
636.3
589.8
512.9
317.7
252.6
53.9
75.4
65.5
56.4
0
10
116280.7
14.5
33.3
0

balance-sheet.row.total-debt

2800700800800
800
850
250
250
0
5.4
126.5
286.2
275
194.2
304.9
250.6
279.2
250
250
0
0
0.8
1.9
1.9
1.9
1.9
0.3

balance-sheet.row.net-debt

-1746.2-507.7-161.2-94.8
61.3
111.6
-419.2
-455.1
-1023
-826.4
-271.2
7.3
121
31.5
52.7
150.2
149.8
110.7
159
-69.2
-82.6
-67.8
-120.8
-22.4
-199
-16.4
-6.5

Cash Flow Statement

The financial landscape of United Therapeutics Corporation has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.126. The company recently extended its share capital by issuing 6.6, marking a difference of 0.000 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -719600000.000 in the reporting currency. This is a shift of -0.113 from the previous year. In the same period, the company recorded 53.2, -23, and -100, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -98 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 193.3, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

984.8984.8727.3475.8
514.8
-104.5
589.2
417.9
713.7
651.6
340.1
174.6
304.4
217.9
105.9
19.5
-42.8
19.9
74
65
15.4
-10
-23.7
-37.3
-75.6
-33.5
-12.8

cash-flows.row.depreciation-and-amortization

53.253.251.349.9
49.9
45.9
35.9
31
31.6
32.9
32.2
31.3
27.1
20.5
17.9
11.4
4.5
1
1.5
2.4
2.3
2.3
3.1
3.5
-0.1
-1.3
0

cash-flows.row.deferred-income-tax

-76.73.6-71.7-89.7
-168.1
-82.7
-104.3
0
0
0
0
0
0
-197.6
41.9
-1
-31.2
-3.3
-37
-18.1
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

39.139.1106.8138.5
163.8
45.4
-26.4
73.5
12.1
280.3
190.1
320.8
30.1
-15.7
113.9
101
28.7
-29.6
-10.8
18.1
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-136.5-97.8-35.1-48.8
4.3
37.3
130.7
-83.2
-46.2
-37.3
-56.7
-22.4
-29.9
-111.3
-74.8
-53.4
10.7
-5.8
-3.2
-7.5
1.4
-3.1
-13.1
-7.2
1.7
1.8
1.2

cash-flows.row.account-receivables

-58.5-58.5-21.7-41.3
-6
24.4
121.4
-82.7
-21.7
-30.5
-35.7
-10
-24
-16.2
-23.5
-22
-2.3
-4
-8.9
-0.2
0
0
-8.3
-196.7
0
0
0

cash-flows.row.inventory

-13.6-13.6-13.4-7.5
10.3
12.9
9.3
-0.5
-24.5
-6.8
-21
-12.4
-5.9
-16.1
-9.2
-9.1
-2.6
-2.3
-1
-3.5
-0.4
-1.2
-1.9
-4
-2.1
0
0

cash-flows.row.account-payables

62.257.1150.6112.9
-16.8
-16.3
0
0
0
0
0
0
0
16.7
-2.7
-3.6
18.5
-1.1
-1.1
-2.1
0
0
-3.4
1825.5
0
0
0

cash-flows.row.other-working-capital

-126.6-82.8-150.6-112.9
16.8
16.3
0
0
0
0
0
0
0
-95.7
-39.4
-18.7
-2.9
1.6
7.7
-1.7
1.8
-1.9
0.4
-1632
3.9
1.8
0

cash-flows.row.other-non-cash-items

114.1-4.923.972.5
191
-148
153.3
25.3
-101.7
-301.7
-17
219.4
-8
336.3
6.6
20.2
-19.1
66.9
27.4
-16.2
1.6
2.1
11.4
2.1
42.8
9.3
2

cash-flows.row.net-cash-provided-by-operating-activities

978000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-230.4-230.4-138.8-120.8
-59.3
-83.7
-184.4
-86.3
-38
-49.8
-47.4
-31.9
-111.9
-36
-18.6
-95.4
-124.4
-38.7
-15.6
-6.1
-5.2
-7
-3.6
-0.7
-0.6
-2.3
-1

cash-flows.row.acquisitions-net

506.5-89.27.1366.1
681.6
-20.5
0
0
0
0
0
0
0
-3.5
0
1.2
-266.1
-260.9
-32.4
0
0.8
0
0
0
-8.1
0
0

cash-flows.row.purchases-of-investments

-2514.3-2514.3-1708.6-1895.3
-2308.8
-1279.5
0
0
0
0
0
0
0
-815.7
-662.2
-310.6
-346
-302
-207.2
-78.1
-37.5
-44.7
-11.2
-152.5
-56.7
-114.3
-10.5

cash-flows.row.sales-maturities-of-investments

2137.32137.31025.31529.2
1627.2
1040.3
0
0
0
0
0
0
0
733.9
457.7
249.1
297.9
318.9
118.8
12.9
30
0
140.6
18.4
76.5
92.6
0

cash-flows.row.other-investing-activites

-618.7-233.5-366.1
-679.2
8
-636.2
-749.3
86.3
553.4
385.9
-263.1
-51.5
0
13.9
-4.8
266.1
260.9
32.4
0
-1
4.2
-5.4
0
-3.9
-0.1
0

cash-flows.row.net-cash-used-for-investing-activites

-719.6-719.6-811.5-486.9
-738.5
-335.4
-820.6
-835.6
48.3
503.6
338.5
-295
-163.4
-121.3
-209.2
-160.5
-172.5
-21.7
-104
-71.3
-12.9
-47.5
120.4
-134.8
7.2
-24.1
-11.5

cash-flows.row.debt-repayment

-100-100-8000
-50
-200
-250
0
-8.8
-133.2
-177.8
-1.3
-1
-251
-31.4
0
0
-59.2
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

43.26.694.355.6
38.5
14
0
0
0
0
0
0
0
27.3
0
0
150
58.3
14.4
15
7.1
4.1
0.2
0
210.6
58.4
22.9

cash-flows.row.common-stock-repurchased

-13.8-13.8-11.4-10.8
-3.7
-2.1
0
-250
-500
-394.5
-483.1
-42.4
-188
0
0
0
0
-67.1
-193.1
0
0
0
0
-2.8
-4.1
0
0

cash-flows.row.dividends-paid

-7.3-98-94.30
-38.5
-14
0
0
0
0
0
0
0
0
0
0
0
-29.6
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

90.5193.3886.8-10.8
36.8
813.3
256.3
43.3
-497.7
-447
-576.6
-5.1
-169.1
5.7
178.2
36.5
63
118.4
252.8
-0.8
-0.8
-2.1
-0.1
-0.1
0.1
0.9
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-11.9-11.975.444.8
-16.9
611.2
6.3
43.3
-497.7
-447
-576.6
-5.1
-169.1
-218.1
146.8
36.5
213
20.9
74.1
14.2
6.3
2
0.2
-2.9
206.6
59.3
22.9

cash-flows.row.effect-of-forex-changes-on-cash

106.6000
0
0
0
0.2
-3
-5.3
-3.8
-0.3
0.2
-0.3
2.8
-2.7
-1.2
0
0
0
0
0
0
0
0
0
21.1

cash-flows.row.net-change-in-cash

246.5246.566.4156.1
0.3
69.2
-35.9
-317.9
191.2
434.1
113.4
124.9
-8.6
-89.5
151.8
-29.1
-9.9
48.3
21.9
-13.4
14.2
-54.1
98.3
-176.6
182.7
11.5
22.9

cash-flows.row.cash-at-end-of-period

4546.21207.7961.2894.8
738.7
738.4
669.2
705.1
1023
831.8
397.7
278.9
154
162.7
252.2
100.4
129.5
139.3
91.1
69.2
82.6
68.6
122.7
24.4
200.9
18.3
27.9

cash-flows.row.cash-at-beginning-of-period

4299.7961.2894.8738.7
738.4
669.2
705.1
1023
831.8
397.7
284.3
154
162.7
252.2
100.4
129.5
139.3
91.1
69.2
82.6
68.4
122.7
24.4
200.9
18.3
6.8
5

cash-flows.row.operating-cash-flow

978978802.5598.2
755.7
-206.6
778.4
474.2
643.6
382.8
355.3
425.3
323.6
250.2
211.5
97.6
-49.2
49.1
51.8
43.7
20.8
-8.6
-22.3
-38.9
-31.1
-23.7
-9.6

cash-flows.row.capital-expenditure

-230.4-230.4-138.8-120.8
-59.3
-83.7
-184.4
-86.3
-43.2
-49.8
-47.4
-31.9
-111.9
-36
-18.6
-95.4
-124.4
-38.7
-15.6
-6.1
-5.2
-7
-3.6
-0.7
-0.6
-2.3
-1

cash-flows.row.free-cash-flow

747.6747.6663.7477.4
696.4
-290.3
594
387.9
600.4
333
307.8
393.4
211.7
214.2
192.9
2.2
-173.6
10.4
36.1
37.6
15.6
-15.6
-25.8
-39.6
-31.8
-26
-10.6

Income Statement Row

United Therapeutics Corporation's revenue saw a change of 0.202% compared with the previous period. The gross profit of UTHR is reported to be 2070. The company's operating expenses are 885.1, showing a change of 9.285% from the last year. The expenses for depreciation and amortization are 53.2, which is a 9.640% change from the last accounting period. Operating expenses are reported to be 885.1, which shows a 9.285% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.209% year-over-year growth. The operating income is 1184.9, which shows a 0.209% change when compared to the previous year. The change in the net income is 0.354%. The net income for the last year was 984.8.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

income-statement-row.row.total-revenue

2327.52327.51936.31685.5
1483.3
1448.8
1627.8
1725.3
1598.8
1465.8
1288.5
1117
916.1
743.2
603.8
369.8
281.5
210.9
159.6
115.9
73.6
53.3
30.1
5.7
2
0.4
0.1

income-statement-row.row.cost-of-revenue

257.5257.5146.7122.5
108.1
117.6
198.7
105.7
72.7
69
125.9
131.1
119.3
88.9
73.5
45.3
30.1
22.3
17
12.3
8.3
6.8
5.5
3.1
1.7
1.4
0

income-statement-row.row.gross-profit

207020701789.61563
1375.2
1331.2
1429.1
1619.6
1526.1
1396.7
1162.6
985.9
796.8
654.3
530.4
324.5
251.4
188.7
142.6
103.6
65.3
46.6
24.7
2.6
0.3
-1
0.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

408---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

395.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

81.8---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-14-14-40.242.2
49.3
22.6
-7.7
13.2
2.4
0.2
4
0.6
31.9
156.5
199.6
176.3
94.3
99
56.1
24.7
21.5
22.7
15.9
0
-0.1
-1.3
2.4

income-statement-row.row.operating-expenses

885.1885.1809.91007.1
781.6
1518.8
623.7
594.7
464.4
697.7
623.8
693.4
375.1
336.5
366.4
298.5
333.5
182.4
113.6
60.7
52.1
58.1
42.7
49.5
81.8
34.4
13.4

income-statement-row.row.cost-and-expenses

1142.61142.6956.61129.6
889.7
1636.4
822.4
700.4
537.1
766.7
749.7
824.5
494.4
425.4
439.8
343.8
363.6
204.6
130.7
73
60.4
64.9
48.1
52.7
83.5
35.8
13.4

income-statement-row.row.interest-income

162.7162.745.216.7
28.6
44.2
28.6
0
0
0
0
3.8
3.9
3.5
2.9
5.1
11
13.6
10.7
5.4
3
2.4
5
10
10.7
0
0

income-statement-row.row.interest-expense

59.359.332.418.6
23.5
44.2
13.9
9
3.9
4.7
17.6
18.1
16.6
21.4
19.7
12.9
0
2.2
0.5
0
0
0.1
0.1
0.2
0.1
0
0

income-statement-row.row.selling-and-marketing-expenses

81.8---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

1.4-14-29.138
45.3
22.6
-61.2
-246.4
2.4
350.2
4
0.6
31.7
-0.7
0.6
0.5
-1.3
-1.1
-1.3
-0.7
-0.7
-0.8
-10.5
-0.2
-4.7
0.1
0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-14-14-40.242.2
49.3
22.6
-7.7
13.2
2.4
0.2
4
0.6
31.9
156.5
199.6
176.3
94.3
99
56.1
24.7
21.5
22.7
15.9
0
-0.1
-1.3
2.4

income-statement-row.row.total-operating-expenses

1.4-14-29.138
45.3
22.6
-61.2
-246.4
2.4
350.2
4
0.6
31.7
-0.7
0.6
0.5
-1.3
-1.1
-1.3
-0.7
-0.7
-0.8
-10.5
-0.2
-4.7
0.1
0.5

income-statement-row.row.interest-expense

59.359.332.418.6
23.5
44.2
13.9
9
3.9
4.7
17.6
18.1
16.6
21.4
19.7
12.9
0
2.2
0.5
0
0
0.1
0.1
0.2
0.1
0
0

income-statement-row.row.depreciation-and-amortization

125.353.2558.9
77.9
66.8
35.9
31
31.6
32.9
32.2
31.3
27.1
20.5
17.9
11.4
4.5
1
1.5
2.4
2.3
2.3
3.1
3.5
-0.1
-1.3
-0.5

income-statement-row.row.ebitda-caps

1360.6---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

1184.91184.9979.7555.9
593.6
-187.6
805.4
814.9
1061.7
699
538.8
292.5
421.6
317.8
164
26
-82.1
6.3
29
42.9
13.2
-11.5
-18
-46.9
-81.5
-35.4
-13.3

income-statement-row.row.income-before-tax

1274.31274.3950.6593.9
638.9
-165
758.9
769.5
1060.2
1044.4
525.2
278.9
440.7
299.1
147.8
18.8
-72.3
16.6
39.9
47.5
15.4
-10
-23.7
-37.3
-86.2
-35.3
-12.8

income-statement-row.row.income-tax-expense

289.5289.5223.3118.1
124.1
-60.5
169.7
351.6
346.5
392.8
185.1
104.3
136.2
81.9
41.9
-0.7
-29.5
-3.3
-34.1
-17.5
-3
-2.5
5.4
-9.7
-5.9
-1.9
0

income-statement-row.row.net-income

984.8984.8727.3475.8
514.8
-104.5
589.2
417.9
713.7
651.6
340.1
174.6
304.4
217.9
105.9
19.5
-42.8
19.9
74
65
15.4
-10
-23.7
-37.3
-75.6
-33.5
-12.8

Frequently Asked Question

What is United Therapeutics Corporation (UTHR) total assets?

United Therapeutics Corporation (UTHR) total assets is 7167000000.000.

What is enterprise annual revenue?

The annual revenue is 1224100000.000.

What is firm profit margin?

Firm profit margin is 0.889.

What is company free cash flow?

The free cash flow is 15.906.

What is enterprise net profit margin?

The net profit margin is 0.423.

What is firm total revenue?

The total revenue is 0.509.

What is United Therapeutics Corporation (UTHR) net profit (net income)?

The net profit (net income) is 984800000.000.

What is firm total debt?

The total debt is 700000000.000.

What is operating expences number?

The operating expences are 885100000.000.

What is company cash figure?

Enretprise cash is 1207700000.000.